Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CORT

Corcept Therapeutics Inc

May 13 • 04:00PM ET

57.08

+5.92 11.57 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: VKTX MDGL KRYS EXEL PTCT

| Held by: IJR VTI FBT VB VBK SPSM IJT VXF IWP SLYG

Scroll to Statements

Index	-	P/E	163.09	EPS (ttm)	0.35	Insider Own	11.86%	Shs Outstand	107.33M	Perf Week	9.45%
Market Cap	6.13B	Forward P/E	29.70	EPS next Y	1.92	Insider Trans	-1.21%	Shs Float	94.62M	Perf Month	30.68%
Enterprise Value	5.80B	PEG	0.44	EPS next Q	0.01	Inst Own	69.95%	Short Float	11.32%	Perf Quarter	39.80%
Income	46.67M	P/S	7.97	EPS this Y	-29.88%	Inst Trans	-1.88%	Short Ratio	6.29	Perf Half Y	-24.39%
Sales	769.10M	P/B	9.60	EPS next Y	234.23%	ROA	5.62%	Short Interest	10.71M	Perf YTD	64.02%
Book/sh	5.94	P/C	18.12	EPS next 5Y	66.81%	ROE	7.06%	52W High	91.00 -37.27%	Perf Year	-19.14%
Cash/sh	3.15	P/FCF	51.15	EPS past 3/5Y	-2.15% -0.84%	ROIC	7.22%	52W Low	28.66 99.16%	Perf 3Y	141.46%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	23.74% 16.56%	Gross Margin	98.25%	Volatility	4.82% 4.27%	Perf 5Y	172.85%
Dividend TTM	-	EV/Sales	7.54	EPS Y/Y TTM	-64.76%	Oper. Margin	-1.07%	ATR (14)	2.36	Perf 10Y	1057.81%
Dividend Ex-Date	-	Quick Ratio	2.74	Sales Y/Y TTM	12.20%	Profit Margin	6.07%	RSI (14)	78.13	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	2.83	EPS Q/Q	-276.49%	SMA20	17.15%	Beta	0.39	Target Price	86.25
Payout	0.00%	Debt/Eq	0.02	Sales Q/Q	4.89%	SMA50	36.03%	Rel Volume	1.37	Prev Close	51.16
Employees	730	LT Debt/Eq	0.01	Earnings	Apr 30 AMC	SMA200	-4.87%	Avg Volume	1.70M	Price	57.08
IPO	Apr 14, 2004	Option/Short	Yes / Yes	EPS/Sales Surpr.	-172.23% -10.99%	Trades		Volume	2,307,963	Change	11.57%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)